Muntaisr T Salah1, Mohamed . Faroug2, Mamoum M Magzoub2, Ishag . Adam3
1Ribat University, Sudan; 2Kassala University, Sudan,; 3Faculty of Medicine, University of Khartoum, Sudan and The Academy of Medical Sciences and Technology.For correspondence:- Ishag Adam Email: ishagadamm@yahoo.com Tel:+ 249912168988
Published: 27 June 2006
Citation: Salah MT, Faroug M., Magzoub MM, Adam I.. Efficacy of artemether-lumfantrine (Co-Artesiane) suspension in the treatment of uncomplicated Plasmodium falciparum malaria among children under 5 years in eastern Sudan. Trop J Pharm Res 2006; 5(1):551-555 doi: 10.4314/tjpr.v5i1.5
© 2006 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Method This was a prospective clinical trial where the artemether-lumfantrine (Co-Artesiane®) suspension was given for three days and the patients were followed-up for 28 days.
Results: Forty-eight patients were enrolled in the study and 43 of them completed the 28- days follow-up. Treatment rapidly cleared parasitemia and fever. The overall 28-day cure rate was 100% and no clinical or parasitological failures were observed among these patients. Mild side effects were observed in three (7%) children.
Conclusion: Artemether-lumfantrine (coartem) suspension appears to be efficacious and safe for the treatment of uncomplicated malaria.
Archives
News Updates